Category
Zanubrutinib
CAS Number
NA
Molecular Formula
C₂₃H₂₆N₄O
Molecular Weight
374.49 g/mol
Synonym

2-(4-Phenoxyphenyl)-7-(piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine

Keywords
Intermediates
Impurities
Metabolites.
Pharmaceutical Standards
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Zanubrutinib De-BOC Acid Impurity is a process-related impurity formed during the synthesis of Zanubrutinib when the BOC (tert-butyloxycarbonyl) protecting group is removed incompletely or under acidic conditions, leading to a deprotected acidic intermediate. It is monitored in pharmaceutical quality control to ensure the purity, safety, and regulatory compliance of the final drug substance.